Global Rare Disease Genetic Testing Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Rare Disease Genetic Testing market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Rare Disease Genetic Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Genetic Testing market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Rare Disease Genetic Testing, covering the supply chain analysis, impact assessment to the Rare Disease Genetic Testing market size growth rate in several scenarios, and the measures to be undertaken by Rare Disease Genetic Testing companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Quest Diagnostics
Macrogen
Centogene
3billion
Arup Laboratories
Invitae Corporation
Ambry Genetics
Eurofins Scientific
Perkin Elmer
Strand Life Sciences
Fulgent Genetics
LabCorp
Myriad Genetics
Baylor Genetics
Progenity
Preventiongenetics
Coopersurgical
Color Genomics
Opko Health
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rare Disease Genetic Testing market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Rare Disease Genetic Testing market by identifying its various subsegments.
Focuses on the key global Rare Disease Genetic Testing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rare Disease Genetic Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Rare Disease Genetic Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rare Disease Genetic Testing Market Size 2015-2025
2.1.2 Rare Disease Genetic Testing Market Size CAGR by Region
2.2 Rare Disease Genetic Testing Segment by Type
2.2.1 Next-Generation Sequencing (NGS)
2.2.2 Next-Generation Sequencing (NGS)
2.2.3 PCR-based Testing
2.2.4 Fluorescence in Situ Hybridization (FISH)
2.2.5 Sanger Sequencing
2.2.6 Karyotyping
2.2.7 Others
2.3 Rare Disease Genetic Testing Market Size by Type
2.3.1 Global Rare Disease Genetic Testing Market Size Market Share by Type (2015-2020)
2.3.2 Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2015-2020)
2.4 Rare Disease Genetic Testing Segment by Application
2.4.1 Research Laboratories and CROs
2.4.2 Diagnostic Laboratories
2.4.3 Hospitals and Clinics
2.4.4 Others
2.5 Rare Disease Genetic Testing Market Size by Application
2.5.1 Global Rare Disease Genetic Testing Market Size Market Share by Application (2015-2020)
2.5.2 Global Rare Disease Genetic Testing Market Size Growth Rate by Application (2015-2020)
3 Global Rare Disease Genetic Testing by Players
3.1 Global Rare Disease Genetic Testing Market Size Market Share by Players
3.1.1 Global Rare Disease Genetic Testing Market Size by Players (2018-2020)
3.1.2 Global Rare Disease Genetic Testing Market Size Market Share by Players (2018-2020)
3.2 Global Rare Disease Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rare Disease Genetic Testing by Regions
4.1 Rare Disease Genetic Testing Market Size by Regions
4.2 Americas Rare Disease Genetic Testing Market Size Growth
4.3 APAC Rare Disease Genetic Testing Market Size Growth
4.4 Europe Rare Disease Genetic Testing Market Size Growth
4.5 Middle East & Africa Rare Disease Genetic Testing Market Size Growth
5 Americas
5.1 Americas Rare Disease Genetic Testing Market Size by Countries
5.2 Americas Rare Disease Genetic Testing Market Size by Type
5.3 Americas Rare Disease Genetic Testing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Rare Disease Genetic Testing Market Size by Regions
6.2 APAC Rare Disease Genetic Testing Market Size by Type
6.3 APAC Rare Disease Genetic Testing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Rare Disease Genetic Testing by Countries
7.2 Europe Rare Disease Genetic Testing Market Size by Type
7.3 Europe Rare Disease Genetic Testing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Rare Disease Genetic Testing by Countries
8.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type
8.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Rare Disease Genetic Testing Market Forecast
10.1 Global Rare Disease Genetic Testing Market Size Forecast (2021-2025)
10.2 Global Rare Disease Genetic Testing Forecast by Regions
10.2.1 Global Rare Disease Genetic Testing Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Rare Disease Genetic Testing Forecast by Type
10.8 Global Rare Disease Genetic Testing Forecast by Application
11 Key Players Analysis
11.1 Quest Diagnostics
11.1.1 Company Details
11.1.2 Rare Disease Genetic Testing Product Offered
11.1.3 Quest Diagnostics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Quest Diagnostics News
11.2 Macrogen
11.2.1 Company Details
11.2.2 Rare Disease Genetic Testing Product Offered
11.2.3 Macrogen Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Macrogen News
11.3 Centogene
11.3.1 Company Details
11.3.2 Rare Disease Genetic Testing Product Offered
11.3.3 Centogene Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Centogene News
11.4 3billion
11.4.1 Company Details
11.4.2 Rare Disease Genetic Testing Product Offered
11.4.3 3billion Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 3billion News
11.5 Arup Laboratories
11.5.1 Company Details
11.5.2 Rare Disease Genetic Testing Product Offered
11.5.3 Arup Laboratories Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Arup Laboratories News
11.6 Invitae Corporation
11.6.1 Company Details
11.6.2 Rare Disease Genetic Testing Product Offered
11.6.3 Invitae Corporation Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Invitae Corporation News
11.7 Ambry Genetics
11.7.1 Company Details
11.7.2 Rare Disease Genetic Testing Product Offered
11.7.3 Ambry Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Ambry Genetics News
11.8 Eurofins Scientific
11.8.1 Company Details
11.8.2 Rare Disease Genetic Testing Product Offered
11.8.3 Eurofins Scientific Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Eurofins Scientific News
11.9 Perkin Elmer
11.9.1 Company Details
11.9.2 Rare Disease Genetic Testing Product Offered
11.9.3 Perkin Elmer Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Perkin Elmer News
11.10 Strand Life Sciences
11.10.1 Company Details
11.10.2 Rare Disease Genetic Testing Product Offered
11.10.3 Strand Life Sciences Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Strand Life Sciences News
11.11 Fulgent Genetics
11.12 LabCorp
11.13 Myriad Genetics
11.14 Baylor Genetics
11.15 Progenity
11.16 Preventiongenetics
11.17 Coopersurgical
11.18 Color Genomics
11.19 Opko Health
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Rare Disease Genetic Testing Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Next-Generation Sequencing (NGS)
Table 5. Major Players of Array Technology
Table 6. Major Players of PCR-based Testing
Table 7. Major Players of Fluorescence in Situ Hybridization (FISH)
Table 8. Major Players of Sanger Sequencing
Table 9. Major Players of Karyotyping
Table 10. Major Players of Others
Table 11. Rare Disease Genetic Testing Market Size by Type (2014-2019) ($ Millions)
Table 12. Global Rare Disease Genetic Testing Market Size Market Share by Type (2015-2020)
Table 13. Global Rare Disease Genetic Testing Market Size by Application (2015-2020) ($ Millions)
Table 14. Global Rare Disease Genetic Testing Market Size Market Share by Application (2015-2020)
Table 15. Global Rare Disease Genetic Testing Revenue by Players (2018-2020) ($ Millions)
Table 16. Global Rare Disease Genetic Testing Revenue Market Share by Players (2018-2020)
Table 17. Global Rare Disease Genetic Testing Key Players Head office and Products Offered
Table 18. Rare Disease Genetic Testing Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Rare Disease Genetic Testing Market Size by Regions 2015-2020 ($ Millions)
Table 22. Global Rare Disease Genetic Testing Market Size Market Share by Regions 2015-2020
Table 23. Americas Rare Disease Genetic Testing Market Size by Countries (2015-2020) ($ Millions)
Table 24. Americas Rare Disease Genetic Testing Market Size Market Share by Countries (2015-2020)
Table 25. Americas Rare Disease Genetic Testing Market Size by Type (2015-2020) ($ Millions)
Table 26. Americas Rare Disease Genetic Testing Market Size Market Share by Type (2015-2020)
Table 27. Americas Rare Disease Genetic Testing Market Size by Application (2015-2020) ($ Millions)
Table 28. Americas Rare Disease Genetic Testing Market Size Market Share by Application (2015-2020)
Table 29. APAC Rare Disease Genetic Testing Market Size by Regions (2015-2020) ($ Millions)
Table 30. APAC Rare Disease Genetic Testing Market Size Market Share by Regions (2015-2020)
Table 31. APAC Rare Disease Genetic Testing Market Size by Type (2015-2020) ($ Millions)
Table 32. APAC Rare Disease Genetic Testing Market Size Market Share by Type (2015-2020)
Table 33. APAC Rare Disease Genetic Testing Market Size by Application (2015-2020) ($ Millions)
Table 34. APAC Rare Disease Genetic Testing Market Size Market Share by Application (2015-2020)
Table 35. Europe Rare Disease Genetic Testing Market Size by Countries (2015-2020) ($ Millions)
Table 36. Europe Rare Disease Genetic Testing Market Size Market Share by Countries (2015-2020)
Table 37. Europe Rare Disease Genetic Testing Market Size by Type (2015-2020) ($ Millions)
Table 38. Europe Rare Disease Genetic Testing Market Size Market Share by Type (2015-2020)
Table 39. Europe Rare Disease Genetic Testing Market Size by Application (2015-2020) ($ Millions)
Table 40. Europe Rare Disease Genetic Testing Market Size Market Share by Application (2015-2020)
Table 41. Middle East & Africa Rare Disease Genetic Testing Market Size by Countries (2015-2020) ($ Millions)
Table 42. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Countries (2015-2020)
Table 43. Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2015-2020) ($ Millions)
Table 44. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Type (2015-2020)
Table 45. Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2015-2020) ($ Millions)
Table 46. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Application (2015-2020)
Table 47. Key and Potential Regions of Rare Disease Genetic Testing
Table 48. Key Application and Potential Industries of Rare Disease Genetic Testing
Table 49. Key Challenges of Rare Disease Genetic Testing
Table 50. Key Trends of Rare Disease Genetic Testing
Table 51. Global Rare Disease Genetic Testing Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 52. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Regions
Table 53. Global Rare Disease Genetic Testing Market Size Forecast by Type (2021-2025) ($ Millions)
Table 54. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Type (2021-2025)
Table 55. Global Rare Disease Genetic Testing Market Size Forecast by Application (2021-2025) ($ Millions)
Table 56. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Application (2021-2025)
Table 57. Quest Diagnostics Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 58. Quest Diagnostics Rare Disease Genetic Testing Product Offered
Table 59. Quest Diagnostics Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 60. Quest Diagnostics Main Business
Table 61. Quest Diagnostics Latest Developments
Table 62. Macrogen Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 63. Macrogen Rare Disease Genetic Testing Product Offered
Table 64. Macrogen Main Business
Table 65. Macrogen Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 66. Macrogen Latest Developments
Table 67. Centogene Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 68. Centogene Rare Disease Genetic Testing Product Offered
Table 69. Centogene Main Business
Table 70. Centogene Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 71. Centogene Latest Developments
Table 72. 3billion Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 73. 3billion Rare Disease Genetic Testing Product Offered
Table 74. 3billion Main Business
Table 75. 3billion Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 76. 3billion Latest Developments
Table 77. Arup Laboratories Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 78. Arup Laboratories Rare Disease Genetic Testing Product Offered
Table 79. Arup Laboratories Main Business
Table 80. Arup Laboratories Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 81. Arup Laboratories Latest Developments
Table 82. Invitae Corporation Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 83. Invitae Corporation Rare Disease Genetic Testing Product Offered
Table 84. Invitae Corporation Main Business
Table 85. Invitae Corporation Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 86. Invitae Corporation Latest Developments
Table 87. Ambry Genetics Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 88. Ambry Genetics Rare Disease Genetic Testing Product Offered
Table 89. Ambry Genetics Main Business
Table 90. Ambry Genetics Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 91. Ambry Genetics Latest Developments
Table 92. Eurofins Scientific Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 93. Eurofins Scientific Rare Disease Genetic Testing Product Offered
Table 94. Eurofins Scientific Main Business
Table 95. Eurofins Scientific Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 96. Eurofins Scientific Latest Developments
Table 97. Perkin Elmer Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 98. Perkin Elmer Rare Disease Genetic Testing Product Offered
Table 99. Perkin Elmer Main Business
Table 100. Perkin Elmer Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 101. Perkin Elmer Latest Developments
Table 102. Strand Life Sciences Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 103. Strand Life Sciences Rare Disease Genetic Testing Product Offered
Table 104. Strand Life Sciences Main Business
Table 105. Strand Life Sciences Rare Disease Genetic Testing Revenue and Gross Margin (2018-2020E)
Table 106. Strand Life Sciences Latest Developments
Table 107. Fulgent Genetics Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 108. LabCorp Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 109. Myriad Genetics Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 110. Baylor Genetics Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 111. Progenity Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 112. Preventiongenetics Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 113. Coopersurgical Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 114. Color Genomics Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
Table 115. Opko Health Details, Company Total Revenue (in $ million), Head Office, Rare Disease Genetic Testing Major Market Areas and Its Competitors
List of Figures
Figure 1. Rare Disease Genetic Testing Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Rare Disease Genetic Testing Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Rare Disease Genetic Testing Market Size Market Share by Type (2015-2020)
Figure 5. Global Next-Generation Sequencing (NGS) Market Size Growth Rate
Figure 6. Global Array Technology Market Size Growth Rate
Figure 7. Global PCR-based Testing Market Size Growth Rate
Figure 8. Global Fluorescence in Situ Hybridization (FISH) Market Size Growth Rate
Figure 9. Global Sanger Sequencing Market Size Growth Rate
Figure 10. Global Karyotyping Market Size Growth Rate
Figure 11. Global Others Market Size Growth Rate
Figure 12. Rare Disease Genetic Testing in Research Laboratories and CROs
Figure 13. Global Rare Disease Genetic Testing Market: Research Laboratories and CROs (2015-2020) ($ Millions)
Figure 14. Rare Disease Genetic Testing in Diagnostic Laboratories
Figure 15. Global Rare Disease Genetic Testing Market: Diagnostic Laboratories (2015-2020) ($ Millions)
Figure 16. Rare Disease Genetic Testing in Hospitals and Clinics
Figure 17. Global Rare Disease Genetic Testing Market: Hospitals and Clinics (2015-2020) ($ Millions)
Figure 18. Global Hospitals and Clinics YoY Growth ($ Millions)
Figure 19. Rare Disease Genetic Testing in Others
Figure 20. Global Rare Disease Genetic Testing Market: Others (2015-2020) ($ Millions)
Figure 21. Global Others YoY Growth ($ Millions)
Figure 22. Global Rare Disease Genetic Testing Market Size Market Share by Application in 2019
Figure 23. Global Rare Disease Genetic Testing Market Size Market Share by Regions 2015-2020
Figure 24. Americas Rare Disease Genetic Testing Market Size 2015-2020 ($ Millions)
Figure 25. APAC Rare Disease Genetic Testing Market Size 2015-2020 ($ Millions)
Figure 26. Europe Rare Disease Genetic Testing Market Size 2015-2020 ($ Millions)
Figure 27. Middle East & Africa Rare Disease Genetic Testing Market Size 2015-2020 ($ Millions)
Figure 28. Americas Rare Disease Genetic Testing Market Size Market Share by Countries in 2019
Figure 29. Americas Rare Disease Genetic Testing Market Size Market Share by Type in 2019
Figure 30. Americas Rare Disease Genetic Testing Market Size Market Share by Application in 2019
Figure 31. United States Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 32. Canada Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 33. Mexico Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 34. APAC Rare Disease Genetic Testing Market Size Market Share by Regions in 2019
Figure 35. APAC Rare Disease Genetic Testing Market Size Market Share by Type in 2019
Figure 36. APAC Rare Disease Genetic Testing Market Size Market Share by Application in 2019
Figure 37. China Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 38. Japan Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 39. Korea Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 40. Southeast Asia Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 41. India Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 42. Australia Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 43. Europe Rare Disease Genetic Testing Market Size Market Share by Countries in 2019
Figure 44. Europe Rare Disease Genetic Testing Market Size Market Share by Type in 2019
Figure 45. Europe Rare Disease Genetic Testing Market Size Market Share by Application in 2019
Figure 46. Germany Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 47. France Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 48. UK Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 49. Italy Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 50. Russia Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 51. Spain Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 52. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Countries in 2019
Figure 53. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Type in 2019
Figure 54. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Application in 2019
Figure 55. Egypt Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 56. South Africa Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 57. Israel Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 58. Turkey Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 59. GCC Countries Rare Disease Genetic Testing Market Size Growth 2015-2020 ($ Millions)
Figure 60. Global Rare Disease Genetic Testing arket Size Forecast (2021-2025) ($ Millions)
Figure 61. Americas Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 62. APAC Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 63. Europe Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 64. Middle East & Africa Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 65. United States Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 66. Canada Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 67. Mexico Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 68. Brazil Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 69. China Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 70. Japan Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 71. Korea Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 72. Southeast Asia Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 73. India Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 74. Australia Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 75. Germany Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 76. France Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 77. UK Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 78. Italy Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 79. Russia Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 80. Spain Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 81. Egypt Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 82. South Africa Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 83. Israel Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 84. Turkey Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
Figure 85. GCC Countries Rare Disease Genetic Testing Market Size 2021-2025 ($ Millions)
